Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2/3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pain, Postoperative 19Breast Neoplasms 12Brain Neoplasms 11Agnosia 7Neoplasms 6Delirium 5Thyroid Neoplasms 4Stomach Neoplasms 4Lung Neoplasms 4Pituitary Neoplasms 3Pain 3Inflammation 3Emergence Delirium 3Colorectal Neoplasms 3Chronic Pain 3Urinary Bladder Neoplasms 2Supratentorial Neoplasms 2Rectal Neoplasms 2Prostatic Neoplasms 2Pheochromocytoma 2Pain, Intractable 2Neoplasm Metastasis 2Liver Neoplasms 2Dexmedetomidine 2Colonic Neoplasms 2Central Nervous System Diseases 2Thrombosis 1Spinal Cord Neoplasms 1Sleep Initiation and Maintenance Disorders 1Sleep Deprivation 1

Interventions

pembrolizumab 155Gemcitabine 139Capecitabine 121Paclitaxel 118Fluorouracil 116Oxaliplatin 110Bevacizumab 104Nivolumab 97Leucovorin 97Docetaxel 92Cisplatin 89Irinotecan 87Carboplatin 84Radiosurgery 83Cyclophosphamide 70Cetuximab 70Magnetic Resonance Spectroscopy 68Trastuzumab 56Specimen Handling 56Biopsy 56Radiotherapy 55Ipilimumab 52Everolimus 48Pemetrexed 46Drug Therapy 45Albumin-Bound Paclitaxel 44130-nm albumin-bound paclitaxel 43Doxorubicin 41Fulvestrant 38aldesleukin 37

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Neoplasm Metastasis × Dexmedetomidine × Clear all
NCT05742438 2025-04-02

Effects of Dexmedetomidine/Lidocaine/Intrathecal Morphine on Cancer Metastasis Biomarker After Colorectal Surgery

Samsung Medical Center

Phase NA Completed
114 enrolled
Gastrointestinal

Inflammation, Neoplasm Metastasis, Colorectal Neoplasms

NCT03936205 2019-05-14

Dexmedetomidine Addition to Morphine in Patients With Metastatic Cancer

Hotel Dieu de France Hospital

Phase 2/3 Completed
18 enrolled

Neoplasm Metastasis, Pain, Intractable

Data powered by HemOnc (CC BY 4.0) Colophon âš¡